graph Evidence gap map comparisons
atezolizumab based treatmentavelumab based treatmentImmune checkpoint association
atezolizumab plus SoC avelumab alone avelumab plus pegylated liposomal doxorubicin avelumab plus SoC nivolumab plus ipilimumab
Comparator:  vs pegylated liposomal doxorubicin;   vs nivolumab alone;   vs Standard of Care (SoC);   vs placebo plus SoC; 
Risk of bias:  low;   some concerns;   high;  NA;